The Official Website of the Long-Term Investor
Results 1 - 10 of 377 : 1 2 3 4 5 6 7 8 9 Next
Biotech Investing for Beginners
3 pointers to help make biotech investing for beginners a little less intimidating.
One Person's Trash Is Another Person's Treasure Portfolio
A year-long exercise intent on proving that value and contrarian investing can be incredibly successful.
2 Scenarios Where Buy and Hold Rarely Works
Historically, buy-and-hold investors will outperform over the long run, but it's not always as simple as it looks if you invest in these two types of companies.
5 of Last Week's Biggest Losers
These five stocks posted double-digit declines this past week.
Dendreon: Picking Through the Carnage
First-quarter results for the prostate cancer drug maker were even uglier than anticipated.
There were a lot of things happening in the market this past week.
3 Horrendous Health-Care Stocks This Week
These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.
Friday's Top Upgrades (and Downgrades)
Analysts shift stance on Raytheon, Workday, and Dendreon.
This Biotech Is Looking for a Fourth-Quarter Comeback
After a crummy quarter, Dendreon looks to ramp up sales
Why Dendreon Had Its Battleship Sunk
Increasing competition and a lack of love from the insurance industry sinks Dendreon's chances of a decent quarter.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK